Medpace Holdings (MEDP) Is Up 6.3% After Q4 Revenue Beats Peers And Analyst Forecasts Has The Bull Case Changed? [Yahoo! Finance]
Medpace (MEDP) was upgraded by Royal Bank Of Canada to "moderate buy".
Medpace (MEDP) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $522.00 price target on the stock.
Evaluating Medpace Holdings (MEDP) After A Sharp 27% One-Month Pullback [Yahoo! Finance]
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know [Yahoo! Finance]